Population-wide benefits of routine vaccination of children against influenza.Vaccine. 2005 Jan 26; 23(10):1284-93.V
Abstract
Using a stochastic simulation model of influenza transmission, clinical illness, and economic costs, we estimated the population-wide benefits of routinely vaccinating US children (ages 6 months to 18 years) against influenza. Disease burden was projected to decline as a result of both reduced susceptibility to infection among vaccinees and reductions in disease transmission to others in the community. Vaccination of 20% of children would reduce the total number of influenza cases in the US by 46%; 80% coverage would reduce the total number of cases by 91%. Similar reductions were estimated to occur in influenza-related mortality and economic costs.
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
15652671
Citation
Weycker, Derek, et al. "Population-wide Benefits of Routine Vaccination of Children Against Influenza." Vaccine, vol. 23, no. 10, 2005, pp. 1284-93.
Weycker D, Edelsberg J, Halloran ME, et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine. 2005;23(10):1284-93.
Weycker, D., Edelsberg, J., Halloran, M. E., Longini, I. M., Nizam, A., Ciuryla, V., & Oster, G. (2005). Population-wide benefits of routine vaccination of children against influenza. Vaccine, 23(10), 1284-93.
Weycker D, et al. Population-wide Benefits of Routine Vaccination of Children Against Influenza. Vaccine. 2005 Jan 26;23(10):1284-93. PubMed PMID: 15652671.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Population-wide benefits of routine vaccination of children against influenza.
AU - Weycker,Derek,
AU - Edelsberg,John,
AU - Halloran,M Elizabeth,
AU - Longini,Ira M,Jr
AU - Nizam,Azhar,
AU - Ciuryla,Vincent,
AU - Oster,Gerry,
PY - 2004/01/26/received
PY - 2004/06/23/revised
PY - 2004/08/16/accepted
PY - 2005/1/18/pubmed
PY - 2005/4/19/medline
PY - 2005/1/18/entrez
SP - 1284
EP - 93
JF - Vaccine
JO - Vaccine
VL - 23
IS - 10
N2 - Using a stochastic simulation model of influenza transmission, clinical illness, and economic costs, we estimated the population-wide benefits of routinely vaccinating US children (ages 6 months to 18 years) against influenza. Disease burden was projected to decline as a result of both reduced susceptibility to infection among vaccinees and reductions in disease transmission to others in the community. Vaccination of 20% of children would reduce the total number of influenza cases in the US by 46%; 80% coverage would reduce the total number of cases by 91%. Similar reductions were estimated to occur in influenza-related mortality and economic costs.
SN - 0264-410X
UR - https://www.unboundmedicine.com/medline/citation/15652671/Population_wide_benefits_of_routine_vaccination_of_children_against_influenza_
DB - PRIME
DP - Unbound Medicine
ER -